Patents Assigned to PROMISE PROTEOMICS
  • Method for quantifying anti-TNF antibodies
    Patent number: 11630111
    Abstract: The present invention relates to a method for quantifying an anti-TNF antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic anti-TNF antibodies a known amount of two or more labeled forms of said anti-TNF antibodies.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: April 18, 2023
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard
  • Method for quantifying therapeutic antibodies
    Patent number: 11543416
    Abstract: The present invention relates to a method for quantifying a therapeutic antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic antibodies to be quantified a known amount of two or more labeled forms of said therapeutic antibodies.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: January 3, 2023
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard
  • Antibody-like peptides for quantifying therapeutic antibodies
    Patent number: 11053303
    Abstract: The present invention relates to a labeled chimeric non-therapeutic antibodylike protein comprising, in a hypervariable region thereof, an enzyme cleavable peptide sequence derived from a hypervariable region of a reference therapeutic antibody.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: July 6, 2021
    Assignee: PROMISE PROTEOMICS
    Inventors: Dorothée Lebert, Guillaume Picard